Retinal Protection Sciences Information

Retinal Protection Sciences (RPS) is focused on maximizing quality of life by preserving vision and preventing vision loss. RPS has developed a novel platform device - SAPRA™ - built around an optimized treatment regimen (Vision Protection Therapy™) that normalizes retinal function at the cellular level and prevents both disease onset and progression. Once validated in a pivotal clinical trial, RPS will be uniquely positioned to establish a preventative standard of care for ophthalmology. SAPRA™ has not yet been evaluated and approved by the U.S. FDA or regulators for other geographies for commercial sales.